454 related articles for article (PubMed ID: 16345041)
1. Non-parametric assessment of non-inferiority with censored data.
Freitag G; Lange S; Munk A
Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
[TBL] [Abstract][Full Text] [Related]
2. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
Pigeot I; Schäfer J; Röhmel J; Hauschke D
Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
[TBL] [Abstract][Full Text] [Related]
3. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
Liu JP; Ma MC; Wu CY; Tai JY
Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
[TBL] [Abstract][Full Text] [Related]
4. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
Hirotsu C
Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
[TBL] [Abstract][Full Text] [Related]
5. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
Matilde Sanchez M; Chen X
Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
[TBL] [Abstract][Full Text] [Related]
6. A score test for establishing non-inferiority with respect to short-term survival in two-sample comparisons with identical proportions of long-term survivors.
Broët P; Tubert-Bitter P; De Rycke Y; Moreau T
Stat Med; 2003 Mar; 22(6):931-40. PubMed ID: 12627410
[TBL] [Abstract][Full Text] [Related]
7. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
Hou Y; Ding V; Li K; Zhou XH
J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
[TBL] [Abstract][Full Text] [Related]
8. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
Mielke M; Munk A; Schacht A
Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
[TBL] [Abstract][Full Text] [Related]
9. Multiple-arm superiority and non-inferiority designs with various endpoints.
Chang M
Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
[TBL] [Abstract][Full Text] [Related]
10. Active-controlled, non-inferiority trials in oncology: arbitrary limits, infeasible sample sizes and uninformative data analysis. is there another way?
Carroll KJ
Pharm Stat; 2006; 5(4):283-93. PubMed ID: 17128427
[TBL] [Abstract][Full Text] [Related]
11. Non-parametric estimators of a monotonic dose-response curve and bootstrap confidence intervals.
Dilleen M; Heimann G; Hirsch I
Stat Med; 2003 Mar; 22(6):869-82. PubMed ID: 12627406
[TBL] [Abstract][Full Text] [Related]
12. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
Tu D
Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
[TBL] [Abstract][Full Text] [Related]
13. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
Sankoh AJ
Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
[TBL] [Abstract][Full Text] [Related]
14. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
Lui KJ; Chang KC
Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
[TBL] [Abstract][Full Text] [Related]
15. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
Liu C; Shen W; Xie J
Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
[TBL] [Abstract][Full Text] [Related]
16. Bio-creep in non-inferiority clinical trials.
Everson-Stewart S; Emerson SS
Stat Med; 2010 Nov; 29(27):2769-80. PubMed ID: 20809482
[TBL] [Abstract][Full Text] [Related]
17. Exact, distribution free confidence intervals for late effects in censored matched pairs.
Daniel SR
Biom J; 2009 Feb; 51(1):31-44. PubMed ID: 19219909
[TBL] [Abstract][Full Text] [Related]
18. A Monte Carlo approach for change-point detection in the Cox proportional hazards model.
Liu M; Lu W; Shao Y
Stat Med; 2008 Aug; 27(19):3894-909. PubMed ID: 18254131
[TBL] [Abstract][Full Text] [Related]
19. Nonparametric non-inferiority analyses in the three-arm design with active control and placebo.
Munzel U
Stat Med; 2009 Dec; 28(29):3643-56. PubMed ID: 19768691
[TBL] [Abstract][Full Text] [Related]
20. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
